Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Niagen Bioscience (NAGE) Non Operating Income (2016 - 2020)

Niagen Bioscience (NAGE) has disclosed Non Operating Income for 10 consecutive years, with -$24000.0 as the latest value for Q2 2020.

  • On a quarterly basis, Non Operating Income fell 119.2% to -$24000.0 in Q2 2020 year-over-year; TTM through Jun 2020 was -$1.0 million, a 6618.75% decrease, with the full-year FY2019 number at -$847000.0, down 488.19% from a year prior.
  • Non Operating Income was -$24000.0 for Q2 2020 at Niagen Bioscience, down from -$12000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $746000.0 in Q3 2017 to a low of -$693000.0 in Q4 2019.
  • A 5-year average of -$70220.7 and a median of -$28000.0 in 2017 define the central range for Non Operating Income.
  • Peak YoY movement for Non Operating Income: soared 266.36% in 2017, then tumbled 3250.0% in 2019.
  • Niagen Bioscience's Non Operating Income stood at -$18360.0 in 2016, then plummeted by 733.33% to -$153000.0 in 2017, then soared by 114.38% to $22000.0 in 2018, then crashed by 3250.0% to -$693000.0 in 2019, then soared by 96.54% to -$24000.0 in 2020.
  • Per Business Quant, the three most recent readings for NAGE's Non Operating Income are -$24000.0 (Q2 2020), -$12000.0 (Q1 2020), and -$693000.0 (Q4 2019).